Posted On: 09/12/2014 12:25:34 PM
Post# of 94182
$ISIS Recent News
This tiny biotech company takes the real ice bucket challenge 10:14 a.m. Sept. 2, 2014 - Michael Brush
A lesson in buying low in a high group 12:01 a.m. Sept. 2, 2014 - Michael Kahn
5 companies that will benefit from ALS awareness 7:58 a.m. Aug. 22, 2014 - Jennifer Booton
Investors blow on the dice as Iraq and the Fed shake up markets 9:09 a.m. June 16, 2014 - Shawn Langlois
S&P, Dow pull in from latest record highs 11:10 a.m. June 2, 2014 - Michael Ashbaugh
Health-care-related stocks keep on giving 1:02 p.m. Feb. 12, 2014 - The Trading Deck
See the future 1:42 p.m. Feb. 3, 2014 - Cody Willard
Charting the S&P 500’s excellent 2013 adventure 12:59 p.m. Dec. 23, 2013 - Michael Ashbaugh
Market technicals tame despite debt-ceiling debate 11:43 a.m. Sept. 25, 2013 - Michael Ashbaugh
Isis reaches a new high on tests for treatment of muscular disorder 3:03 p.m. Sept. 19, 2013 - Russ Britt
Isis, Biogen working on ways to fight disease through gene altering 10:59 a.m. Sept. 9, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 11:48 a.m. Sept. 3, 2013 - Russ Britt
Despite positive tests, investors let some air out of Isis Pharmaceuticals 11:30 a.m. July 22, 2013 - Russ Britt
5 stocks to watch 3:35 p.m. July 11, 2013 - The Trading Deck
Onyx share surge lifts several boats in biotech harbor, including ETFs 11:33 a.m. July 1, 2013 - Russ Britt
S&P’s 50-day average marks the technical test 11:39 a.m. June 27, 2013 - Michael Ashbaugh
After the close: Alexion climbs on FDA news, Biogen basks in glory 5:35 p.m. June 26, 2013 - Russ Britt
After dramatic moves, Isis and Allergan dart in different directions 6:18 p.m. June 25, 2013 - Russ Britt
Dissecting the close: Isis soars on data, while Pfizer loses on spin-off 7:26 p.m. June 24, 2013 - Russ Britt
3 ways to play the biotech boom 7:01 a.m. June 3, 2013 - Jeff Reeves
Jim Cramer's Top Stock Picks: TWTR TASR ACAD ISIS RH 6:00 a.m. Today - TheStreet.com
Cramer's Mad Money - 2 Biotech Takeover Targets (9/11/14) 5:47 a.m. Today - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Enjoy This Bull Market While It Lasts 7:47 p.m. Sept. 11, 2014 - TheStreet.com
Trade-Ideas: Isis Pharmaceuticals (ISIS) Is Today's Post-Market Leader Stock 6:57 p.m. Sept. 11, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – ISIS PBYI KERX HALO 1:30 p.m. Sept. 11, 2014 - InvestorPlace.com
'Mad Money' Lightning Round: Buy, Buy, Buy Flextronics 6:00 a.m. Sept. 11, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: This Is Why Apple Rules 8:10 p.m. Sept. 10, 2014 - TheStreet.com
Making Money With Charles Payne: 08/29/14 10:33 a.m. Sept. 3, 2014 - FOXBusiness
Isis Pharmaceuticals Starts Phase III Study on ISIS-APOCIIIRx - Analyst Blog 4:55 p.m. Aug. 29, 2014 - Zacks.com
Biotech Stocks 101 — What Investors Need to Know 6:59 a.m. Aug. 29, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – LCI ISIS CNC ACHN 8:00 a.m. Aug. 28, 2014 - InvestorPlace.com
Companies With 'ISIS' Name Get Unwanted Attention 3:06 p.m. Aug. 27, 2014 - FOXBusiness
Isis Pharmaceuticals, Inc. (ISIS) Surges: Stock Moves 10.8% Higher - Tale of the Tape 9:11 a.m. Aug. 27, 2014 - Zacks.com
CNBC's Stock Pops & Drops From August 26 7:16 p.m. Aug. 26, 2014 - benzinga.com
Biggest Movers in Healthcare Stocks Now – ISIS THRX EXAS CBPO 6:00 a.m. Aug. 26, 2014 - InvestorPlace.com
Fast Money Picks For August 26 7:03 p.m. Aug. 25, 2014 - benzinga.com
Hottest Healthcare Stocks Now – PBYI ISIS EXAS IMGN 8:30 a.m. Aug. 25, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – PRGO WX ISIS TARO 8:30 a.m. Aug. 14, 2014 - InvestorPlace.com
UPDATE: Laidlow & Co. Initiates Coverage on Isis Pharmaceuticals, Inc. at Buy, Announces $52.00 PT 10:34 a.m. Aug. 12, 2014 - benzinga.com
Alnylam Pharmaceuticals Has Plenty On Its Plate 10:36 a.m. Aug. 9, 2014 - Seeking Alpha
Isis Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference 7:00 a.m. Sept. 3, 2014 - PR Newswire - PRF
ATL1103 Phase II Trial - Successful Efficacy Results 7:19 p.m. Sept. 2, 2014 - PR Newswire - PRF
Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 7:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Upcoming Conferences Schedule, Clinical Trial Data Release Schedule, Milestone Payment, and Expansion of Partnership - Research Reports on Celgene, Actavis, Regeneron, ISIS and UnitedHealth 9:10 a.m. Aug. 29, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-APOCIII Rx in Patients with FCS 7:00 a.m. Aug. 28, 2014 - PR Newswire - PRF
Orphan Diseases Partnering Terms and Agreements 9:10 p.m. Aug. 27, 2014 - PR Newswire - PRF
Critical Alerts For Arrowhead Research, Isis Pharmaceuticals, MobileIron, JP Morgan Chase and Viacom Released By InvestorsObserver 9:31 a.m. Aug. 27, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $2M from the Advancement of ISIS-SMN Rx in Children with Spinal Muscular Atrophy 7:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Expert Briefing on Biotech Stocks -- Nanosphere, Vanda Pharma, Synta Pharma, Halozyme Therapeutics, and Isis Pharma 9:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Critical Alerts For Stratasys, Horizon Pharma, Isis Pharmaceuticals, Amgen, and Discover Financial Services Released By InvestorsObserver 9:31 a.m. Aug. 8, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 7:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 7:00 a.m. July 28, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 2 Study of ISIS-APO(a) Rx in Patients with High Lp(a) 7:00 a.m. July 17, 2014 - PR Newswire - PRF
Critical Alerts For Cninsure, Freeport-McMoRan, Level 3 Communications, Electronic Arts, and Isis Pharmaceuticals Released By InvestorsObserver 9:31 a.m. July 16, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $1 Million from GSK for Advancing ISIS-TTR Rx 7:00 a.m. July 16, 2014 - PR Newswire - PRF
Type 2 Diabetes Global Clinical Trials Review, H1, 2014 3:31 p.m. July 15, 2014 - PR Newswire - PRF
Biotech Equities Technical Momentum -- Research on Organovo, Prana Biotechnology, Isis Pharma, and Pharmacyclics 7:04 a.m. July 14, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $1 Million From GSK for Advancing Hepatitis B Virus Program 7:00 a.m. July 2, 2014 - PR Newswire - PRF
Critical Alerts For General Electric, Deere, Isis Pharmaceuticals, Expedia, and Sears Holdings Released By InvestorsObserver 9:31 a.m. June 26, 2014 - PR Newswire - PRF
Global Diabetic Retinopathy Market 2014-2018 12:22 p.m. June 25, 2014 - PR Newswire - PRF
This tiny biotech company takes the real ice bucket challenge 10:14 a.m. Sept. 2, 2014 - Michael Brush
A lesson in buying low in a high group 12:01 a.m. Sept. 2, 2014 - Michael Kahn
5 companies that will benefit from ALS awareness 7:58 a.m. Aug. 22, 2014 - Jennifer Booton
Investors blow on the dice as Iraq and the Fed shake up markets 9:09 a.m. June 16, 2014 - Shawn Langlois
S&P, Dow pull in from latest record highs 11:10 a.m. June 2, 2014 - Michael Ashbaugh
Health-care-related stocks keep on giving 1:02 p.m. Feb. 12, 2014 - The Trading Deck
See the future 1:42 p.m. Feb. 3, 2014 - Cody Willard
Charting the S&P 500’s excellent 2013 adventure 12:59 p.m. Dec. 23, 2013 - Michael Ashbaugh
Market technicals tame despite debt-ceiling debate 11:43 a.m. Sept. 25, 2013 - Michael Ashbaugh
Isis reaches a new high on tests for treatment of muscular disorder 3:03 p.m. Sept. 19, 2013 - Russ Britt
Isis, Biogen working on ways to fight disease through gene altering 10:59 a.m. Sept. 9, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 11:48 a.m. Sept. 3, 2013 - Russ Britt
Despite positive tests, investors let some air out of Isis Pharmaceuticals 11:30 a.m. July 22, 2013 - Russ Britt
5 stocks to watch 3:35 p.m. July 11, 2013 - The Trading Deck
Onyx share surge lifts several boats in biotech harbor, including ETFs 11:33 a.m. July 1, 2013 - Russ Britt
S&P’s 50-day average marks the technical test 11:39 a.m. June 27, 2013 - Michael Ashbaugh
After the close: Alexion climbs on FDA news, Biogen basks in glory 5:35 p.m. June 26, 2013 - Russ Britt
After dramatic moves, Isis and Allergan dart in different directions 6:18 p.m. June 25, 2013 - Russ Britt
Dissecting the close: Isis soars on data, while Pfizer loses on spin-off 7:26 p.m. June 24, 2013 - Russ Britt
3 ways to play the biotech boom 7:01 a.m. June 3, 2013 - Jeff Reeves
Jim Cramer's Top Stock Picks: TWTR TASR ACAD ISIS RH 6:00 a.m. Today - TheStreet.com
Cramer's Mad Money - 2 Biotech Takeover Targets (9/11/14) 5:47 a.m. Today - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Enjoy This Bull Market While It Lasts 7:47 p.m. Sept. 11, 2014 - TheStreet.com
Trade-Ideas: Isis Pharmaceuticals (ISIS) Is Today's Post-Market Leader Stock 6:57 p.m. Sept. 11, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – ISIS PBYI KERX HALO 1:30 p.m. Sept. 11, 2014 - InvestorPlace.com
'Mad Money' Lightning Round: Buy, Buy, Buy Flextronics 6:00 a.m. Sept. 11, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: This Is Why Apple Rules 8:10 p.m. Sept. 10, 2014 - TheStreet.com
Making Money With Charles Payne: 08/29/14 10:33 a.m. Sept. 3, 2014 - FOXBusiness
Isis Pharmaceuticals Starts Phase III Study on ISIS-APOCIIIRx - Analyst Blog 4:55 p.m. Aug. 29, 2014 - Zacks.com
Biotech Stocks 101 — What Investors Need to Know 6:59 a.m. Aug. 29, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – LCI ISIS CNC ACHN 8:00 a.m. Aug. 28, 2014 - InvestorPlace.com
Companies With 'ISIS' Name Get Unwanted Attention 3:06 p.m. Aug. 27, 2014 - FOXBusiness
Isis Pharmaceuticals, Inc. (ISIS) Surges: Stock Moves 10.8% Higher - Tale of the Tape 9:11 a.m. Aug. 27, 2014 - Zacks.com
CNBC's Stock Pops & Drops From August 26 7:16 p.m. Aug. 26, 2014 - benzinga.com
Biggest Movers in Healthcare Stocks Now – ISIS THRX EXAS CBPO 6:00 a.m. Aug. 26, 2014 - InvestorPlace.com
Fast Money Picks For August 26 7:03 p.m. Aug. 25, 2014 - benzinga.com
Hottest Healthcare Stocks Now – PBYI ISIS EXAS IMGN 8:30 a.m. Aug. 25, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – PRGO WX ISIS TARO 8:30 a.m. Aug. 14, 2014 - InvestorPlace.com
UPDATE: Laidlow & Co. Initiates Coverage on Isis Pharmaceuticals, Inc. at Buy, Announces $52.00 PT 10:34 a.m. Aug. 12, 2014 - benzinga.com
Alnylam Pharmaceuticals Has Plenty On Its Plate 10:36 a.m. Aug. 9, 2014 - Seeking Alpha
Isis Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference 7:00 a.m. Sept. 3, 2014 - PR Newswire - PRF
ATL1103 Phase II Trial - Successful Efficacy Results 7:19 p.m. Sept. 2, 2014 - PR Newswire - PRF
Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 7:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Upcoming Conferences Schedule, Clinical Trial Data Release Schedule, Milestone Payment, and Expansion of Partnership - Research Reports on Celgene, Actavis, Regeneron, ISIS and UnitedHealth 9:10 a.m. Aug. 29, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-APOCIII Rx in Patients with FCS 7:00 a.m. Aug. 28, 2014 - PR Newswire - PRF
Orphan Diseases Partnering Terms and Agreements 9:10 p.m. Aug. 27, 2014 - PR Newswire - PRF
Critical Alerts For Arrowhead Research, Isis Pharmaceuticals, MobileIron, JP Morgan Chase and Viacom Released By InvestorsObserver 9:31 a.m. Aug. 27, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $2M from the Advancement of ISIS-SMN Rx in Children with Spinal Muscular Atrophy 7:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Expert Briefing on Biotech Stocks -- Nanosphere, Vanda Pharma, Synta Pharma, Halozyme Therapeutics, and Isis Pharma 9:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Critical Alerts For Stratasys, Horizon Pharma, Isis Pharmaceuticals, Amgen, and Discover Financial Services Released By InvestorsObserver 9:31 a.m. Aug. 8, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 7:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 7:00 a.m. July 28, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 2 Study of ISIS-APO(a) Rx in Patients with High Lp(a) 7:00 a.m. July 17, 2014 - PR Newswire - PRF
Critical Alerts For Cninsure, Freeport-McMoRan, Level 3 Communications, Electronic Arts, and Isis Pharmaceuticals Released By InvestorsObserver 9:31 a.m. July 16, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $1 Million from GSK for Advancing ISIS-TTR Rx 7:00 a.m. July 16, 2014 - PR Newswire - PRF
Type 2 Diabetes Global Clinical Trials Review, H1, 2014 3:31 p.m. July 15, 2014 - PR Newswire - PRF
Biotech Equities Technical Momentum -- Research on Organovo, Prana Biotechnology, Isis Pharma, and Pharmacyclics 7:04 a.m. July 14, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Earns $1 Million From GSK for Advancing Hepatitis B Virus Program 7:00 a.m. July 2, 2014 - PR Newswire - PRF
Critical Alerts For General Electric, Deere, Isis Pharmaceuticals, Expedia, and Sears Holdings Released By InvestorsObserver 9:31 a.m. June 26, 2014 - PR Newswire - PRF
Global Diabetic Retinopathy Market 2014-2018 12:22 p.m. June 25, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼
